4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Piramal Pharma Limited (PPLPHARMA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 7,120 employees. Its market capitalization is roughly ₹276 billion. In the fiscal year ended 2026-03-31, PPLPHARMA reported ₹87.6B in revenue and (₹3.3B) in net income.
Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹87.6B | ₹90.6B | ₹81.1B | ₹70.3B | — |
| Gross Profit | ₹51.8B | ₹54.9B | ₹48.5B | ₹40.3B | — |
| Operating Income (EBIT) | ₹1.5B | ₹6.8B | ₹4.6B | (₹480M) | — |
| Net Income | (₹3.3B) | ₹911M | ₹178M | (₹1.9B) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹22.7B | ₹27.5B | ₹21.4B | ₹19.3B | ₹27.5B |
| Gross Profit | ₹14.2B | ₹17.0B | ₹13.5B | ₹12.4B | ₹18.0B |
| Operating Income (EBIT) | (₹284M) | ₹2.4B | (₹170M) | (₹906M) | ₹3.2B |
| Net Income | (₹694M) | (₹88M) | (₹1.4B) | (₹817M) | ₹1.5B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹186M) | (₹145M) | — | (₹670M) | (₹500M) |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹179.7B | ₹156.8B | ₹153.1B | ₹145.2B | — |
| Total Liabilities | ₹98.0B | ₹75.5B | ₹74.0B | ₹77.5B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PPLPHARMA viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms